目的总结不同激素分泌类型垂体瘤患者人群分布及临床特征,分析近16年垂体瘤疾病谱变化,指导临床诊疗。
方法收集2005年1月1日至2020年12月31日在解放军总医院第一医学中心首次住院诊疗的4 276例垂体瘤患者的病例资料,包括性别、年龄、入院日期、临床诊断、是否手术、术后病理诊断等,对其进行回顾性分析。
结果(1)16年间就诊于解放军总医院第一医学中心的垂体瘤患者共4 276例,其中男性1 871例(占比43.76%),女性2 405例(占比56.24%),平均就诊年龄(44.1±13.9)岁。(2)垂体瘤以无功能瘤(占比60.67%)、泌乳素瘤(16.10%)、生长激素瘤(13.93%)居多,无功能瘤多集中于41~60岁人群,泌乳素瘤、生长激素瘤多集中于21~40岁人群。(3)随时间进展,垂体瘤患者住院例数呈现逐步增加的趋势,高峰出现在2012年,垂体生长激素瘤及垂体促肾上腺皮质激素瘤患者占比呈现逐年增加趋势,而无功能瘤患者占比呈现下降趋势。
结论垂体无功能瘤、泌乳素瘤、生长激素瘤仍是临床最常见的3种垂体瘤,住院垂体无功能瘤病例占比随时间进展呈现逐步下降趋势。
ObjectiveTo summarize the distribution and clinical characteristics of patients with pituitary adenoma of different hormone secreting types, analyze the changes of the disease spectrum and to guide clinical diagnosis and treatment.
MethodsAll clinical data of patients with pituitary adenoma hospitalized in the First Medical Center of PLA General Hospital from Jan.1st 2005 to Dec.31rd 2020 were collected. The profile of gender ratio, age, date of admission, clinical diagnosis were retrospectively analyzed.
ResultsA total of 4 276 patients with pituitary adenoma were treated during 16 years, including 1 871 males (43.8%) and 2 405 females (56.2%) with the average age of consultation was (44.1±13.9) years. Non-functioning adenoma (60.7%), prolactinoma (16.1%) and growth hormone adenoma (13.9%) were at relatively high proportion. The visiting age of non-functioning adenoma was mostly concentrated between 41~60 years, and prolactinoma and growth hormone adenoma were mostly concentrated between 21~40 years. The number of patients with pituitary adenoma gradually increased with a peak in 2012, while the proportion of patients with growth hormone adenoma and adrenocorticotropic hormone adenoma increased and the proportion of patients with non-functional adenoma decreased slightly.
ConclusionNon-functional pituitary adenoma, prolactinoma, and growth hormone adenoma are still the most common pituitary adenoma in clinical practice. The proportion of hospitalized non-functional pituitary adenoma showes a gradual decline over time.
李一君,谷伟军,王岳鹏,等. 4 276例垂体瘤的回顾性临床分析[J]. 国际内分泌代谢杂志,2022,42(01):7-11.
DOI:10.3760/cma.j.cn121383-20211110-11036版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。